Calcium Levofolinate
- Generic Name
- Calcium Levofolinate
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
与5-氟尿嘧啶合用，用于治疗胃癌和结直肠癌。
- Associated Conditions
- -
- Associated Therapies
- -
Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-09-21
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- University Hospital, Grenoble
- Target Recruit Count
- 52
- Registration Number
- NCT05546853
- Locations
- 🇫🇷
CHU de GRENOBLE ALPES, Grenoble, Alpes, France
🇫🇷CHU de BORDEAUX, Bordeaux, France
🇫🇷CHRU Lille, Lille, France
Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Azienda Unità Sanitaria Locale Reggio Emilia
- Target Recruit Count
- 280
- Registration Number
- NCT04776655
- Locations
- 🇮🇹
Azienda ULSS 3 Serenissima, Mirano, VE, Italy
🇮🇹Ospedale Civile di Guastalla, Guastalla, Reggio Emilia, Italy
🇮🇹Ospedale San Salvatore, Coppito, L'Aquila, Italy
mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA
- First Posted Date
- 2017-02-07
- Last Posted Date
- 2017-02-07
- Lead Sponsor
- Fujian Cancer Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT03045770
- Locations
- 🇨🇳
Jianwei Yang, Fuzhou, Fujian, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath